Constellation Pharmaceuticals, Inc. EBITDA 2018-2021 | CNST
Constellation Pharmaceuticals, Inc. ebitda from 2018 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Constellation Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2020 | $-124 |
| 2019 | $-86 |
| 2018 | $-61 |
| 2017 | $-39 |
| 2016 | $-33 |
| Constellation Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2021-03-31 | $-40 |
| 2020-12-31 | $-36 |
| 2020-09-30 | $-33 |
| 2020-06-30 | $-30 |
| 2020-03-31 | $-26 |
| 2019-12-31 | $-24 |
| 2019-09-30 | $-21 |
| 2019-06-30 | $-21 |
| 2019-03-31 | $-20 |
| 2018-12-31 | $-20 |
| 2018-09-30 | $-16 |
| 2018-06-30 | $-12 |
| 2018-03-31 | $-12 |
| 2017-09-30 | $-10 |
| 2017-06-30 | $-10 |
